{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T22:31:41Z","timestamp":1774045901113,"version":"3.50.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2005,1,12]],"date-time":"2005-01-12T00:00:00Z","timestamp":1105488000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2005,5]]},"DOI":"10.1007\/s00213-004-2079-0","type":"journal-article","created":{"date-parts":[[2005,1,11]],"date-time":"2005-01-11T11:20:57Z","timestamp":1105442457000},"page":"678-687","source":"Crossref","is-referenced-by-count":30,"title":["Spontaneous and precipitated withdrawal after chronic intragastric administration of gamma-hydroxybutyrate (GHB) in baboons"],"prefix":"10.1007","volume":"179","author":[{"given":"Elise M.","family":"Weerts","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy K.","family":"Goodwin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roland R.","family":"Griffiths","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. Rand","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolfgang","family":"Froestl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cornelis","family":"Jakobs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. Michael","family":"Gibson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2005,1,12]]},"reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1093\/oxfordjournals.alcalc.a008160","volume":"31","author":"G Addolorato","year":"1996","unstructured":"Addolorato G, Castelli E, Stefanini GF, Casella G, Caputo F, Marsigli L, Bernardi M, Gasbarrini G (1996) An open multicentric study evaluating 4-hydroxybutyric acid sodium salt in the medium-term treatment of 179 alcohol dependent subjects. GHB Study Group. Alcohol Alcoholism 31:341\u2013345","journal-title":"Alcohol Alcoholism"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0140-6736(05)78088-0","volume":"351","author":"G Addolorato","year":"1998","unstructured":"Addolorato G, Cibin M, Capristo E, Beghe F, Gessa G, Stefanini GF, Gasbarrini G (1998a) Maintaining abstinence from alcohol with gamma-hydroxybutyric acid. Lancet 351:38","journal-title":"Lancet"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0376-8716(98)00094-5","volume":"53","author":"G Addolorato","year":"1998","unstructured":"Addolorato G, Cibin M, Caputo F, Capristo E, Gessa GL, Stefanini GF, Gasbarrini G (1998b) Gamma-hydroxybutyric acid in the treatment of alcoholism: dosage fractioning utility in non-responder alcoholic patients. Drug Alcohol Depend 53:7\u201310","journal-title":"Drug Alcohol Depend"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1097\/00002826-199901000-00011","volume":"22","author":"G Addolorato","year":"1999","unstructured":"Addolorato G, Caputo F, Capristo E, Bernardi M, Stefanini GF, Gasbarrini G (1999) A case of gamma-hydroxybutyric acid withdrawal syndrome during alcohol addiction treatment: utility of diazepam administration. Clin Neuropharmacol 22:60\u201362","journal-title":"Clin Neuropharmacol"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1197\/aemj.10.7.697","volume":"10","author":"TC Bania","year":"2003","unstructured":"Bania TC, Ashar T, Press G, Carey PM (2003) Gamma-hydroxybutyric acid tolerance and withdrawal in a rat model. Acad Emerg Med 10:697\u2013704","journal-title":"Acad Emerg Med"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0741-8329(99)00085-3","volume":"20","author":"F Beghe","year":"2000","unstructured":"Beghe F, Carpanini MT (2000) Safety and tolerability of gamma-hydroxybutyric acid in the treatment of alcohol-dependent patients. Alcohol 20:223\u2013225","journal-title":"Alcohol"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1177\/0091270003262795","volume":"44","author":"LA Borgen","year":"2004","unstructured":"Borgen LA, Okerholm RA, Lai A, Scharf MB (2004) The pharmacokinetics of sodium oxybate oral solution following acute and chronic administration to narcoleptic patients. J Clin Pharmacol 44:253\u2013257","journal-title":"J Clin Pharmacol"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0014-2999(01)01334-6","volume":"428","author":"MA Carai","year":"2001","unstructured":"Carai MA, Colombo G, Brunetti G, Melis S, Serra S, Vacca G, Mastinu S, Pistuddi AM, Solinas C, Cignarella G, Minardi G, Gessa GL (2001) Role of GABA(B) receptors in the sedative\/hypnotic effect of gamma-hydroxybutyric acid. Eur J Pharmacol 428:315\u2013321","journal-title":"Eur J Pharmacol"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0014-2999(94)00687-3","volume":"273","author":"G Colombo","year":"1995","unstructured":"Colombo G, Agabio R, Lobina C, Reali R, Fadda F, Gessa GL (1995) Cross-tolerance to ethanol and gamma-hydroxybutyric acid. Eur J Pharmacol 273:235\u2013238","journal-title":"Eur J Pharmacol"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0031-9384(98)00062-6","volume":"64","author":"G Colombo","year":"1998","unstructured":"Colombo G, Agabio R, Lobina C, Reali R, Gessa GL, (1998) Involvement of GABA(A) and GABA(B) receptors in the mediation of discriminative stimulus effects of gamma-hydroxybutyric acid. Physiol Behav 64:293\u2013302","journal-title":"Physiol Behav"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s00213-001-0951-8","volume":"160","author":"CD Cook","year":"2002","unstructured":"Cook CD, Aceto MD, Coop A, Beardsley PM, (2002) Effects of the putative antagonist NCS382 on the behavioral pharmacological actions of gammahydroxybutyrate in mice. Psychopharmacology 160:99\u2013106","journal-title":"Psychopharmacology"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1081\/CLT-120019128","volume":"41","author":"HOM Cook","year":"2003","unstructured":"Cook HOM (2003) The abrupt cessation of therapeutically administered sodium oxybate (GHB) does not cause withdrawal symptoms. J Toxicol Clin Toxicol 41:131\u2013135","journal-title":"J Toxicol Clin Toxicol"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0736-4679(99)00163-8","volume":"18","author":"K Craig","year":"2000","unstructured":"Craig K, Gomez HF, McManus JL, Bania TC (2000) Severe gamma-hydroxybutyrate withdrawal: a case report and literature review. J Emerg Med 18:65\u201370","journal-title":"J Emerg Med"},{"key":"CR14","unstructured":"DEA\/ODE, 2000. Gamma hydroxybutyric acid (GHB, liquid X, Goop, Georgia Home Boy). Drug Enforcement Agency, Office of Diversion Control, Washington, D.C."},{"key":"CR15","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1067\/mem.2001.112985","volume":"37","author":"JE Dyer","year":"2001","unstructured":"Dyer JE, Roth B, Hyma BA, Gamma-hydroxybutyrate withdrawal syndrome. Ann Emerg Med 37:147\u2013153","journal-title":"Ann Emerg Med"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1212\/WNL.46.2.469","volume":"46","author":"J Friedman","year":"1996","unstructured":"Friedman J, Westlake R, Furman M (1996) \u201cGrievous bodily harm\u201d: gamma hydroxybutyrate abuse leading to a Wernicke\u2013Korsakoff syndrome. Neurology 46:469\u2013471","journal-title":"Neurology"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S0140-6736(89)90842-8","volume":"2","author":"L Gallimberti","year":"1989","unstructured":"Gallimberti L, Canton G, Gentile N, Ferri M, Cibin M, Ferrara SD, Fadda F, Gessa GL (1989) Gamma-hydroxybutyric acid for treatment of alcohol withdrawal syndrome. Lancet 2:787\u2013789","journal-title":"Lancet"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/j.1530-0277.1992.tb00658.x","volume":"16","author":"L Gallimberti","year":"1992","unstructured":"Gallimberti L, Ferri M, Ferrara SD, Fadda F, Gessa GL (1992) Gamma-hydroxybutyric acid in the treatment of alcohol dependence: a double-blind study. Alcohol Clin Exp Res 16:673\u2013676","journal-title":"Alcohol Clin Exp Res"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1360-0443.1997.tb03640.x","volume":"92","author":"GP Galloway","year":"1997","unstructured":"Galloway GP, Frederick SL, Staggers FE, Gonzales M, Stalcup SA, Smith DE (1997) Gamma-hydroxybutyrate: an emerging drug of abuse that causes physical dependence. Addiction 92:89\u201396","journal-title":"Addiction"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/bms.1200190207","volume":"19","author":"KM Gibson","year":"1990","unstructured":"Gibson KM, Aramaki S, Sweetman L, Nyhan WL, DeVivo DC, Hodson AK Jakobs C (1990) Stable isotope dilution analysis of 4-hydroxybutyric acid: an accurate method for quantification in physiological fluids and the prenatal diagnosis of 4-hydroxybutyric aciduria. Biomed Environ Mass Spectrom 19:89\u201393","journal-title":"Biomed Environ Mass Spectrom"},{"key":"CR21","doi-asserted-by":"crossref","unstructured":"Goodwin AK, Froestl W, Weerts EM (in press) Involvement of gamma-hydroxybutyrate (GHB) and GABA-B receptors in the acute behavioral effects of GHB in baboons. Psychopharmacology","DOI":"10.1007\/s00213-005-2165-y"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s002130050422","volume":"134","author":"RR Griffiths","year":"1997","unstructured":"Griffiths RR, Weerts EM, (1997) Benzodiazepine self-administration in humans and laboratory animals\u2014implications for problems of long-term use and abuse. Psychopharmacology 134:1\u201337","journal-title":"Psychopharmacology"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1176\/appi.ajp.157.10.1706","volume":"157","author":"B Hutto","year":"2000","unstructured":"Hutto B, Fairchild A, Bright R (2000) Gamma-hydroxybutyrate withdrawal and chloral hydrate. Am J Psychiatry 157:1706","journal-title":"Am J Psychiatry"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1749-6632.2002.tb04186.x","volume":"965","author":"Y Itzhak","year":"2002","unstructured":"Itzhak Y, Ali SF (2002) Repeated administration of gamma-hydroxybutyric acid (GHB) to mice: assessment of the sedative and rewarding effects of GHB. Ann N Y Acad Sci 965:451\u2013460","journal-title":"Ann N Y Acad Sci"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/01.fbp.0000082131.08343.0e","volume":"14","author":"BJ Kaminski","year":"2003","unstructured":"Kaminski BJ, Sannerud CA, Weerts EM, Lamb RJ, Griffiths RR (2003) Physical dependence in baboons chronically treated with low and high doses of diazepam. Behav Pharmacol 14:331\u2013342","journal-title":"Behav Pharmacol"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0091-3057(99)00046-5","volume":"64","author":"C Lobina","year":"1999","unstructured":"Lobina C, Agabio R, Reali R, Gessa GL, Colombo G (1999) Contribution of GABA(A) and GABA(B) receptors to the discriminative stimulus produced by gamma-hydroxybutyric acid. Pharmacol Biochem Behav 64:363\u2013365","journal-title":"Pharmacol Biochem Behav"},{"key":"CR27","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0091-3057(83)90373-8","volume":"18","author":"SE Lukas","year":"1983","unstructured":"Lukas SE (1983) Subcutaneous splicing of intravenous and intragastric catheters. Pharmacol Biochem Behav 18:267\u2013268","journal-title":"Pharmacol Biochem Behav"},{"key":"CR28","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/0091-3057(82)90366-5","volume":"17","author":"SE Lukas","year":"1982","unstructured":"Lukas SE, Griffiths RR, Bradford LD, Brady JV, Daley L (1982) A tethering system for intravenous and intragastric drug administration in the baboon. Pharmacol Biochem Behav 17:823\u2013829","journal-title":"Pharmacol Biochem Behav"},{"key":"CR29","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0301-0082(96)00064-0","volume":"51","author":"M Maitre","year":"1997","unstructured":"Maitre M (1997) The gamma-hydroxybutyrate signalling system in brain: organization and functional implications. Prog Neurobiol 51:337\u2013361","journal-title":"Prog Neurobiol"},{"key":"CR30","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1093\/sleep\/9.1.285","volume":"9","author":"M Mamelak","year":"1986","unstructured":"Mamelak M, Scharf MB, Woods M (1986) Treatment of narcolepsy with gamma-hydroxybutyrate. A review of clinical and sleep laboratory findings. Sleep 9:285\u2013289","journal-title":"Sleep"},{"key":"CR31","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1197\/aemj.9.7.730","volume":"9","author":"PE Mason","year":"2002","unstructured":"Mason PE, Kerns WP II (2002) Gamma hydroxybutyric acid (GHB) intoxication. Acad Emerg Med 9:730\u2013739","journal-title":"Acad Emerg Med"},{"key":"CR32","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.drugalcdep.2004.01.012","volume":"75","author":"M McDonough","year":"2004","unstructured":"McDonough M, Kennedy N, Glasper A, Bearn J (2004) Clinical features and management of gamma-hydroxybutyrate (GHB) withdrawal: a review. Drug Alcohol Depend 75:3\u20139","journal-title":"Drug Alcohol Depend"},{"key":"CR33","volume-title":"Guide for the care and use of laboratory animals","author":"National Academy of Sciences","year":"1996","unstructured":"National Academy of Sciences (1996) Guide for the care and use of laboratory animals. National Academy Press, Washington, D.C."},{"key":"CR34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0376-8716(00)00191-5","volume":"63","author":"KL Nicholson","year":"2001","unstructured":"Nicholson KL, Balster RL (2001) GHB: a new and novel drug of abuse. Drug Alcohol Depend 63:1\u201322","journal-title":"Drug Alcohol Depend"},{"key":"CR35","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1007\/BF01271186","volume":"103","author":"H Nissbrandt","year":"1996","unstructured":"Nissbrandt H, Engberg G (1996) The GABAB-receptor antagonist, CGP 35348, antagonises gamma-hydroxybutyrate- and baclofen-induced alterations in locomotor activity and forebrain dopamine levels in mice. J Neural Transm 103:1255\u20131263","journal-title":"J Neural Transm"},{"key":"CR36","first-page":"14","volume":"34","author":"T Nordenberg","year":"2000","unstructured":"Nordenberg T (2000) The death of the party. All the rave, GHB\u2019s hazards go unheeded. FDA Consum 34:14\u201316, 18\u201319","journal-title":"FDA Consum"},{"key":"CR37","first-page":"2478","volume":"62","author":"T O\u2019Connell","year":"2000","unstructured":"O\u2019Connell T, Kaye L, Plosay JJ III (2000) Gamma-hydroxybutyrate (GHB): a newer drug of abuse. Am Fam Phys 62:2478\u20132483","journal-title":"Am Fam Phys"},{"key":"CR38","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1192\/bjp.177.2.181","volume":"177","author":"G Price","year":"2000","unstructured":"Price G (2000) In-patient detoxification after GHB dependence. Br J Psychiatry 177:181","journal-title":"Br J Psychiatry"},{"key":"CR39","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1081\/ADA-120020529","volume":"29","author":"MH Rosenberg","year":"2003","unstructured":"Rosenberg MH, Deerfield LJ, Baruch EM (2003) Two cases of severe gamma-hydroxybutyrate withdrawal delirium on a psychiatric unit: recommendations for management. Am J Drug Alcohol Abuse 29:487\u2013496","journal-title":"Am J Drug Alcohol Abuse"},{"key":"CR40","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1093\/sleep\/21.5.507","volume":"21","author":"MB Scharf","year":"1998","unstructured":"Scharf MB, Lai AA, Branigan B, Stover R, Berkowitz DB (1998) Pharmacokinetics of gammahydroxybutyrate (GHB) in narcoleptic patients. Sleep 21:507\u2013514","journal-title":"Sleep"},{"key":"CR41","volume-title":"Tactics of scientific research","author":"M Sidman","year":"1960","unstructured":"Sidman M (1960) Tactics of scientific research. Basic Books, New York"},{"key":"CR42","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1212\/WNL.28.7.636","volume":"28","author":"OC Snead","year":"1978","unstructured":"Snead OC (1978) Gamma hydroxybutyrate in the monkey. I. Electroencephalographic, behavioral, and pharmacokinetic studies. Neurology 28:636\u2013642","journal-title":"Neurology"},{"key":"CR43","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0091-3057(95)00200-6","volume":"53","author":"OC Snead","year":"1996","unstructured":"Snead OC (1996) Antiabsence seizure activity of specific GABA-B and gamma-hydroxybutyric acid receptor antagonists. Pharmacol Biochem Behav 53:73\u201379","journal-title":"Pharmacol Biochem Behav"},{"key":"CR44","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s00213-003-1410-5","volume":"168","author":"EM Weerts","year":"2003","unstructured":"Weerts EM, Griffiths RR (2003) The adenosine receptor antagonist CGS15943 reinstates cocaine-seeking behavior and maintains self-administration in baboons. Psychopharmacology 168:155\u2013163","journal-title":"Psychopharmacology"},{"key":"CR45","first-page":"41","volume":"285","author":"EM Weerts","year":"1998","unstructured":"Weerts EM, Ator NA, Grech DM, Griffiths RR (1998) Zolpidem physical dependence assessed across increasing doses under a once-daily dosing regimen in baboons. J Pharmacol Exp Ther 285:41\u201353","journal-title":"J Pharmacol Exp Ther"},{"key":"CR46","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.tips.2003.11.001","volume":"25","author":"CG Wong","year":"2004","unstructured":"Wong CG, Gibson KM, Snead OC 3rd (2004) From the street to the brain: neurobiology of the recreational drug gamma-hydroxybutyric acid. Trends Pharmacol Sci 25:29\u201334","journal-title":"Trends Pharmacol Sci"},{"key":"CR47","first-page":"151","volume":"44","author":"JH Woods","year":"1992","unstructured":"Woods JH, Katz JL, Winger G (1992) Benzodiazepines: use, abuse, and consequences. Pharmacol Rev 44: 151\u2013347","journal-title":"Pharmacol Rev"},{"key":"CR48","first-page":"163","volume":"172","author":"T Yanagita","year":"1970","unstructured":"Yanagita T, Takahashi S (1970) Development of tolerance to and physical dependence on barbiturates in rhesus monkeys. J Pharmacol Exp Ther 172:163\u2013169","journal-title":"J Pharmacol Exp Ther"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-004-2079-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-004-2079-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-004-2079-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T20:01:23Z","timestamp":1558641683000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-004-2079-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,1,12]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,5]]}},"alternative-id":["2079"],"URL":"https:\/\/doi.org\/10.1007\/s00213-004-2079-0","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,1,12]]}}}